Atopic Keratoconjunctivitis Clinical Trial
Official title:
Ocular Comorbidity in Atopic Dermatitis
A clinical characterization of a large cohort of patients with different severities of AD and ocular symptoms/atopic keratoconjunktivitis (AKC). The data will contribute to assess the frequency of complications in order to give a rationale for focused prevention and treatment strategy.
Atopic Dermatitis (AD), a very common inflammatory skin condition of child and adulthood, is strongly associated with ocular disease. Accordingly, about 20% experience conjunctivitis at some point, and many have chronic disease. Atopic keratoconjunctivitis (AKC) is the most feared as it may lead to blindness. Little is known about the etiology, the immune infiltrate, as well as predictive factors of AKC and the clinical characteristics of AD patients who develop this entity. We expect this project to enable clinicians to better identify AKC patients in the future as well as improve the understanding of the pathogenesis of AKC. The ocular findings will be compared between AD severity and a control group without ocular symptoms. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03557203 -
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
|
||
| Completed |
NCT03379311 -
A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
|
Phase 1 | |
| Recruiting |
NCT04296864 -
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
|
Phase 2 | |
| Completed |
NCT00987467 -
Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis
|
N/A |